Amrutanjan Health Care Limited (BOM: 590006)

Amrutanjan Health Care Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	4,271	4,212	3,796	4,058	3,328	2,615
Other Revenue	-	1.41	1.23	1.06	1.69	2.72
Revenue	4,271	4,214	3,798	4,059	3,330	2,617
Revenue Growth (YoY)	10.49%	10.96%	-6.45%	21.90%	27.23%	3.24%
Cost of Revenue	2,152	2,170	1,874	1,838	1,432	1,200
Gross Profit	2,119	2,043	1,924	2,221	1,899	1,418
Selling, General & Admin	1,048	484.02	492.2	484.84	420.53	834.18
Other Operating Expenses	588.45	1,026	960	879.76	647.2	272.26
Operating Expenses	1,699	1,571	1,505	1,423	1,181	1,150
Operating Income	419.49	472.47	418.55	798.41	717.93	267.76
Interest Expense	-1.97	-1.57	-0.77	-4.85	-5	-2.21
Interest & Investment Income	-	148.05	117.83	111.7	93.88	65.72
Currency Exchange Gain (Loss)	-	0.62	2.38	1.25	0.59	1.33
Other Non Operating Income (Expenses)	171.14	0.69	0.24	0.83	0.42	1.31
EBT Excluding Unusual Items	588.65	620.26	538.23	907.34	807.82	333.92
Gain (Loss) on Sale of Investments	-	-1.26	-2.05	-1.57	-3.67	10.62
Gain (Loss) on Sale of Assets	-	1.57	0.27	-	0.89	-
Asset Writedown	-	-1.11	-	-	-	-
Pretax Income	588.65	619.46	536.45	905.77	819.05	344.54
Income Tax Expense	162.92	169.73	138.11	233.88	207.14	93.71
Earnings From Continuing Operations	425.73	449.73	398.35	671.89	611.9	250.83
Net Income	425.73	449.73	398.35	671.89	611.9	250.83
Net Income to Common	425.73	449.73	398.35	671.89	611.9	250.83
Net Income Growth	-1.42%	12.90%	-40.71%	9.80%	143.95%	2.32%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
Shares Change (YoY)	-1.08%	-0.71%	-0.03%	0.00%	0.02%	-0.00%
EPS (Basic)	14.72	15.50	13.65	23.00	20.94	8.58
EPS (Diluted)	14.72	15.50	13.63	22.98	20.93	8.58
EPS Growth	-0.34%	13.70%	-40.69%	9.79%	143.94%	2.31%
Free Cash Flow	-	211.93	112.54	287.32	889.09	156.32
Free Cash Flow Per Share	-	7.30	3.85	9.83	30.41	5.35
Dividend Per Share	-	4.600	4.600	4.600	4.200	1.100
Dividend Growth	-	0%	0%	9.52%	281.82%	-48.84%
Gross Margin	49.61%	48.49%	50.65%	54.72%	57.01%	54.17%
Operating Margin	9.82%	11.21%	11.02%	19.67%	21.56%	10.23%
Profit Margin	9.97%	10.67%	10.49%	16.55%	18.37%	9.58%
Free Cash Flow Margin	-	5.03%	2.96%	7.08%	26.70%	5.97%
EBITDA	485.17	520.33	458.66	830.49	747.3	304.87
EBITDA Margin	11.36%	12.35%	12.08%	20.46%	22.44%	11.65%
D&A For EBITDA	65.68	47.86	40.11	32.09	29.37	37.12
EBIT	419.49	472.47	418.55	798.41	717.93	267.76
EBIT Margin	9.82%	11.21%	11.02%	19.67%	21.56%	10.23%
Effective Tax Rate	27.68%	27.40%	25.74%	25.82%	25.29%	27.20%
Revenue as Reported	4,442	4,376	3,942	4,212	3,442	2,698
Advertising Expenses	-	-	-	-	-	435.05

Source: S&P Capital IQ. Standard template. Financial Sources.